Search Results for "Cvs Minute Clinic Shingles Vaccine"

22:50 EDT 26th March 2017 | BioPortfolio

Matching Channels


Varicella zoster virus (VZV) is one of eight herpes viruses known to infect humans (and other vertebrates). Varicella-zoster virus is known by many names, including: chickenpox virus, varicella viru...

HPV vaccine

Rotavirus Vaccine GSK

Smallpox Vaccine MVA

Poliovirus Vaccine OPV

Matching News

GSK applies for FDA approval for shingles vaccine

GlaxoSmithKlien, the UK’s biggest drugmaker, is seeking approval from the FDA for a shingles (herpes zoster) vaccine. The vaccine would be for those of 50 years and above to prevent the emergence of...

GSK Seeks Approval for its Blockbuster Shingles Vaccine

GlaxoSmithKline  plc (LSE/NYSE: GSK) today announced that it has submitted a Biologics License Application (BLA) for its candidate shingles vaccine, ShingrixTM, to the United States Food and Drug Ad...

GSK seeks EU approval for shingles vaccine

GlaxoSmithKline (GSK) has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) seeking approval for its shingles vaccine candidate dubbed Shingrix, for herpes z...

UPDATE: GSK is staging a comeback with a new Shingles Vaccine

GSK is banishing concerns about its health with a BLA submission for Shingrix, which has outperformed Merck’s standard and could bring GSK close to €1Bn. London-based GSK has just submitted a ...

GSK presents new data backing shingles vaccine

GSK has unveiled new data for its shingles candidate vaccine Shingrix from trials assessing its co-administration with the flu vaccine, dosing schedule and quality of life.

BRIEF-GlaxoSmithKline submits marketing application for shingles vaccine to EMA

* GSK announces EU regulatory submission of candidate vaccine for prevention of shingles

GSK Files BLA for Shingles Vaccine to Compete with Merck

GSK announces U.S. regulatory submission of potential $1 billion Shingrix vaccine for prevention of shingles

BRIEF-GSK submits U.S. application for Shingles vaccine

* Announces U.S. regulatory submission of candidate vaccine for prevention of Shingles

Matching PubMed Articles

Vaccination Coverage Among Adults With Diagnosed Diabetes: United States, 2015.

Data from the National Health Interview Survey •Among adults aged 18 and over with diagnosed diabetes, 61.6% had an influenza vaccine in the past year. •A total of 52.6% of adults with diagnosed d...

The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.

Multiple vaccination visits and administrations can be stressful for infants, parents and healthcare providers. Multivalent combination vaccines can deliver the required number of antigens in fewer in...

Safety profile of the varicella vaccine (Oka vaccine strain) based on reported cases from 2005 to 2015 in Japan.

As of 2014, routine vaccination strategies in Japan have included the varicella vaccine. Given the widespread use of the vaccine, it is important to investigate the safety profile of the vaccine strai...

Modeling HIV vaccine trials of the future.

Models of implementation of known-effective interventions for HIV prevention indicate that an efficacious vaccine to prevent HIV infection would be critical for controlling the HIV pandemic. Key issue...

Adult immunisation: General points, hot topics and perspectives.

Vaccination in immunocompetent adult mainly concerns booster vaccination against diphtheria, tetanus, polio and pertussis. Some chronic diseases may also require the achievement of pneumococcal and in...

Search Whole site using Google

Quick Search
Advertisement Advertisement